跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 999 条关于
“neutrophilic eccrine hidradenitis”
全部
999
临床试验
800
药物
20
机构
1
资讯
178
上个月
High-Dose Oral Vitamin D Shows Rapid Relief for Cancer Therapy–Induced Skin Toxicities
去年
Fedratinib Shows Efficacy in Rare Myeloid Neoplasms: Phase 2 Trial Results
10个月前
InflaRx's Oral C5aR Inhibitor INF904 Shows Biologic-Like Efficacy in Phase 2a Trials for Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
去年
24+ Companies Advancing Hidradenitis Suppurativa Treatment Pipeline with Novel Therapies
9个月前
EpiEndo's Glasmacinal Shows Promise in First COPD Clinical Trial, Reduces Neutrophilic Inflammation Without Antimicrobial Resistance
去年
Bimekizumab Approved by FDA for Moderate to Severe Hidradenitis Suppurativa
去年
FDA Approves Bimzelx (bimekizumab) as First IL-17A/F Inhibitor for Hidradenitis Suppurativa
去年
Hidradenitis Suppurativa: Advances in Treatment and Research Highlighted in 2024
去年
FDA Approves Bimekizumab-bkzx (Bimzelx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
Novartis Secures Canadian Public Reimbursement for Cosentyx in Hidradenitis Suppurativa
第 1 页，共 18 页
上一页
下一页
